» Articles » PMID: 19006694

Retinoic Acid Enhances Foxp3 Induction Indirectly by Relieving Inhibition from CD4+CD44hi Cells

Overview
Journal Immunity
Publisher Cell Press
Date 2008 Nov 14
PMID 19006694
Citations 196
Authors
Affiliations
Soon will be listed here.
Abstract

CD4(+)Foxp3(+) regulatory T (Treg) cells originate primarily from thymic differentiation, but conversion of mature T lymphocytes to Foxp3 positivity can be elicited by several means, including in vitro activation in the presence of TGF-beta. Retinoic acid (RA) increases TGF-beta-induced expression of Foxp3, through unknown molecular mechanisms. We showed here that, rather than enhancing TGF-beta signaling directly in naive CD4(+) T cells, RA negatively regulated an accompanying population of CD4(+) T cells with a CD44(hi) memory and effector phenotype. These memory cells actively inhibited the TGF-beta-induced conversion of naive CD4(+) T cells through the synthesis of a set of cytokines (IL-4, IL-21, IFN-gamma) whose expression was coordinately curtailed by RA. This indirect effect was evident in vivo and required the expression of the RA receptor alpha. Thus, cytokine-producing CD44(hi) cells actively restrain TGF-beta-mediated Foxp3 expression in naive T cells, and this balance can be shifted or fine-tuned by RA.

Citing Articles

Maintenance DNA methylation is required for induced regulatory T cell reparative function following viral pneumonia.

Joudi A, Gurkan J, Liu Q, Acosta M, Helmin K, Morales-Nebreda L bioRxiv. 2025; .

PMID: 40060513 PMC: 11888461. DOI: 10.1101/2025.02.25.640199.


Retinoic Acid (RA): A Critical Immunoregulatory Molecule in Asthma and Allergies.

Lotfi R Immun Inflamm Dis. 2024; 12(10):e70051.

PMID: 39466149 PMC: 11514501. DOI: 10.1002/iid3.70051.


The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes.

Esposito M, Amory J, Kang Y J Exp Med. 2024; 221(9).

PMID: 39133222 PMC: 11318670. DOI: 10.1084/jem.20240519.


Distal Immunization and Systemic Cytokines Establish a Transient Immune Alert State in the Intestine.

Wu Y, Huang J, Conlon M, Shenoy M, Chao J, Chooi M J Immunol. 2024; 213(3):373-383.

PMID: 38884660 PMC: 11250722. DOI: 10.4049/jimmunol.2400209.


Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis.

Zhang J, Liu H, Chen Y, Liu H, Zhang S, Yin G Front Immunol. 2024; 15:1312919.

PMID: 38322264 PMC: 10844451. DOI: 10.3389/fimmu.2024.1312919.


References
1.
Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan A, Stroud J . FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 2006; 126(2):375-87. DOI: 10.1016/j.cell.2006.05.042. View

2.
Apostolou I, von Boehmer H . In vivo instruction of suppressor commitment in naive T cells. J Exp Med. 2004; 199(10):1401-8. PMC: 2211808. DOI: 10.1084/jem.20040249. View

3.
Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z . Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006; 212:8-27. DOI: 10.1111/j.0105-2896.2006.00427.x. View

4.
Kang S, Lim H, Andrisani O, Broxmeyer H, Kim C . Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol. 2007; 179(6):3724-33. DOI: 10.4049/jimmunol.179.6.3724. View

5.
Huehn J, Siegmund K, Lehmann J, Siewert C, Haubold U, Feuerer M . Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med. 2004; 199(3):303-13. PMC: 2211798. DOI: 10.1084/jem.20031562. View